CHRNA7 and Stroke: An important distinction is that most studies investigating the effect of α7nAChR agonists and/or antagonists on brain injury have used other models, such as hemorrhagic stroke [21,52], photothrombotic stroke [20] or permanent MCAO (pMCAO) [53–55].